Outcomes research in oncology: Improving patients' experiences with cancer treatment

Clinical Therapeutics

Volumn 25, Issue 2, 2003, Pages 665-670

  Schulman, Kevin A ^a,b   Seils, Damon M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER THERAPY; COMMUNITY; CONTROLLED STUDY; HUMAN; MEDICAL RESEARCH; ONCOLOGY; SUPPLEMENTATION;

EID: 0037291237     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80103-0     Document Type: Article

References (31)

1. Lee SJ, Earle CC, Weeks JC. Outcomes research in oncology: History, conceptual framework, and trends in the literature. J Natl Cancer Inst. 2000;92:195-204.
2. Integrating economic analysis into cancer clinical trials: The National Cancer Institute-American Society of Clinical Oncology Economics Workbook. J Natl Cancer Inst Monogr. 1998;24:1-28.
3. McCabe MS. A cooperative group report on quality-of-life research: Lessons learned. J Natl Cancer Inst Monogr. 1996;20:63-65.
4. Neymark N, Kiebert W, Torfs K, et al. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop. Eur J Cancer. 1998;34:1317-1333.
5. Schulman KA, Glick HA, Yabroff KR, Eisenberg JM. Introduction to clinical economics: Assessment of cancer therapies. J Natl Cancer Inst Monogr. 1995;19:1-9.
6. Long-Term Follow-up Study. University of Minnesota Cancer Center Web site. Available at: http://www.cancer.umn.edu/ltfu/. Accessed December 2, 2002.
7. Children's Oncology Group Web site. Available at: http://www.childrensoncology-group.org/. Accessed December 2, 2002.
8. Hewitt M, Simone JV, eds. Ensuring Quality Cancer Care. Washington, DC: Institute of Medicine; 1999.
9. Gaskin DJ, Kong J, Meropol NJ, et al. Treatment choices by seriously ill patients: The Health Stock Risk Adjustment model. Med Decis Making. 1998;18:84-94.
10. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995;13:1062-1072.
11. Keating NL, Guadagnoli E, Landrum MB, et al. Treatment decision making in early-stage breast cancer: Should surgeons match patients' desired level of involvement? J Clin Oncol. 2002;20:1473-1479.
12. Polsky D, Keating NL, Weeks JC, Schulman KA. Patient choice of breast cancer treatment. Med Care. 2002;40:1068-1079.
13. Mitchell JM, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: The role of sociodemographic factors. J Clin Oncol. 1997;15:2644-2651.
14. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
15. Bach PB, Schrag D, Brawley OW, et al. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
16. Schrag D, Gelfand SE, Bach PB, et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from Surveillance, Epidemiology, and End Results - Medicare. J Clin Oncol. 2001;19:3712-3718.
17. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer. 2000;89:561-573.
18. Penson DF, Stoddard ML, Pasta DJ, et al. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol. 2001;54:350-358.
19. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001;93:501-515.
20. Jenney ME, Levitt GA. The quality of survival after childhood cancer. Eur J Cancer. 2002;38:1241-1250.
21. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3:19-30.
22. Einbinder LC, Schulman KA. The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev. 2000;57(Suppl 1):162-180.
23. Seils DM, Friedman JY, Schulman KA. Sex differences in the referral process for invasive cardiac procedures. J Am Med Womens Assoc. 2001;56:151-154, 160.
24. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583-589.
25. Yabroff KR, Boekeloo BO, Seils DM, Schulman KA. Measuring information framing in a clinical setting: A novel approach in instrument development. Presented at: American Psychological Association, "Psychosocial and Behavioral Factors in Women's Health: Research, Prevention, Treatment, and Service Delivery in Clinical and Community Settings"; September 19-21, 1996; Washington, DC.
26. Birkmeyer JD, Sharp SM, Finlayson SR, et al. Variation profiles of common surgical procedures. Surgery. 1998;124:917-923.
27. Petersen M. 2 Drug makers to pay $875 million to settle fraud case. New York Times, October 4, 2001; C1.
28. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345:181-188.
29. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol. 2000;18:2327-2340.
30. Hillner BE, Smith TJ. Hospital volume and patient outcomes in major cancer surgery: A catalyst for quality assessment and concentration of cancer services. JAMA. 1998;280:1783-1784.
31. Schrag D, Panageas KS, Riedel E, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg. 2002;236:583-592.